MST1, a member of the Group II GC kinases. Endogekinases in Ras action is unknown, considerable evinous NORE and MST1 occur in a constitutive complex dence indicates that the catalytic subunits of the Type in vivo that associates with endogenous Ras after serum 1 PI 3-kinases are bona fide Ras effectors. These p110 stimulation. Targeting recombinant MST1 to the mempolypeptides each bind specifically to Ras-GTP through brane, either through NORE or myristoylation, augments a structurally conserved domain; mutation within this the apoptotic efficacy of MST1. Overexpression of condomain that interrupts Ras-GTP binding increases basal stitutively active Ki-RasG12V promotes apoptosis in a PI 3-kinase activity and significantly reduces RTK activavariety of cell lines; Ha-RasG12V is a much less potent tion of PI 3-kinase activity in vivo [9] . A third class of proapoptotic agent; however, a Ha-RasG12V effector probable Ras effectors is the family of guanylnucleotide loop mutant (E37G) that binds NORE, but not Raf or exchange factors active on the Ral A GTPase (Ral-GDS, PI 3-kinase, exhibits proapoptotic efficacy approaching Rgl, Rlf). These polypeptides also bind selectively to that of Ki-RasG12V. The apoptotic action of both Ki-
Ras-GTP through a conserved noncatalytic domain [10]. RasG12V and Ha-RasG12V, E37G is suppressed by
In addition, several noncatalytic polypeptides have been overexpression of the MST1 carboxy-terminal noncataisolated by their ability to bind specifically to Ras-GTP, lytic segment or by the NORE segment that binds MST1.
including AF-6 [11], Rin1 [12], and NORE [13] ; the latter is the subject of this report.
Conclusions: MST1 is a phylogenetically conserved
Ras was first identified in mutant, active form as a partner of the NORE/RASSF polypeptide family, and the retroviral-transforming agent. Moreover, mutations con-NORE-MST1 complex is a novel Ras effector unit that ferring constitutive Ras activation are found in nearly mediates the apoptotic effect of Ki-RasG12V.
30% of all human tumors [4] . Although active Ras mutants are able to transform nearly all immortalized cell Background lines, they are usually unable to transform normal primary cells [14] , except in the presence of a cooperating Ras is a small GTPase imbedded on the inner surface oncogene [15] [16] [17] or in association with the loss of cerof the plasma membrane whose primary function is to tain tumor suppressor genes [18, 19] . Introduction of relay proliferative and developmental signals downconstitutively active Ras into primary cells generally restream of cell surface receptors, especially, but not exsults in cell cycle arrest mediated by increased levels clusively, receptor tyrosine kinases [1]. Ras signaling is of a variety of cyclin-dependent kinase inhibitors, or activated on binding GTP, which results in the reconfiguin apoptosis [19] [20] [21] . Downregulation of the pathways ration of two epitopes on the cytoplasmic face of the mediating cell cycle arrest and/or apoptosis is probably crucial to the expression of Ras-induced oncogenesis. The mechanism by which Ras promotes G1 cell cycle [13] . Although we showed previously [13] that NORE baits; however, only one also bound to T24F1.3, a murine binds directly to Ras-GTP and is recruited to cRas in vivo cDNA encoding the Ste20-related protein kinase MST1 in response to EGF, the biologic roles and biochemical ( Figure 1A ). The prior demonstration that MST1 can act functions of NORE are as yet unknown as a proapoptotic agent impelled us to examine further NORE is most closely related in structure to a family this evolutionarily conserved interaction. We elected to of human polypeptides encoded by the RASSF1 gene focus on the NORE-MST1 interaction, in view of the on Chr3p21 [ Figure 1A) . The 270 amino acid RASSF1C isoform Little is known concerning the physiologic regulation of is identical over its C-terminal 221 amino acids to the MST1. As for the targets downstream of MST1, no effect longer RASSF1 polypeptides but contains a unique 49 on ERK 1/2 activity has been observed, and activation amino acid N-terminal segment; RASSF1C thus lacks of coexpressed SAPK/JNK or p38 has been observed the C1 zinc finger motif but contains the RA domain. in some reports [ As seen in the upper panel, the FLAG-MST1 polypeptide is recovered in the RasG12V immunoprecipitate, but Our polyclonal anti-NORE antibodies do not enable reliable immunoprecipitation of endogenous NORE. We only in the presence of coexpressed NORE. Moreover, by comparing the intensities of FLAG-NORE and FLAGtherefore expressed recombinant HA-tagged NORE and probed the HA immunoprecipitate for endogenous MST1 in the cell extract to that of the Ras IP, it can be estimated that, in the presence of an excess of RasG12V, MST1; in addition, FLAG-tagged MST1 was expressed simultaneously in increasing amounts. As seen in Figure about 20% of both FLAG-NORE and coexpressed FLAG-MST1 are recovered in the RasG12V immunopre-2B, an immunoreactive band is observed in the ␣MST1 immunoblot of the HA-NORE immunoprecipitate that is cipitate. Thus active Ras is able to bind the NORE-MST1 complex. GST-NORE and GST Raf (1-257) each bind in identical in mobility to the MST1 band observed in the cell extract. Moreover, the increasing expression of the vitro slightly better to Ki-RasG12V than to Ha-RasG12V, whereas GST RASSF1A binds neither Ras polypeptide slightly larger FLAG-MST1 is accompanied by the appearance of increasing amounts of a slightly larger ( Figure 3B ). We showed previously that the Ras binds NORE through the Ras effector loop; mutation of Ras ␣MST1-reactive polypeptide in the HA-NORE immunoprecipitates, which ultimately displaces entirely the enAsp38 to Ala or Asn abolishes Ras binding to NORE [13] . Here, we examine the ability of several other Hadogenous MST1 polypeptide. Thus, MST1 and NORE form a complex in vivo, which is constitutive (or at least RasG12V effector loop mutants to bind NORE during transient expression ( Figure 3C ). The mutation Hainsensitive to serum withdrawal/addition) and saturable.
RasT35S greatly diminishes, and Y40C abolishes, the HA-RasG12V-NORE interaction; conversely, the HaActive Ras Binds the NORE-MST1 Complex In Vivo We next determined whether the NORE-MST1 complex RasG12V, E37G mutant exhibits unimpaired (and perhaps enhanced) binding to NORE. is able to interact with active Ras. A constant amount antiapoptotic protein p35 CrmA ( Figure 5B and data not tecture, and nuclear and cytoplasmic fragmentation resulting in apoptotic bodies ( Figure 5C ). In addition, coexshown) or by preincubation with zVAD-FMK (data not shown). Moreover, although the appearance of HEK293 pression of Ki-RasG12V with dominant inhibitory mutants of caspase 3, 6, 7, and 9 each substantially suppressed cells overexpressing Ha-RasG12V did not differ significantly from GFP controls, expression of Ki-RasG12V the Ki-RasG12V-induced cell death, whereas dominant inhibitory caspase 8 had no effect ( Figure 5B) . Thus, and Ha-RasG12V, E37G is accompanied by changes in cell morphology characteristic of apoptotic cell death, the cell death elicited by Ki-RasG12V and Ha-RasG12V, E37G in HEK293 cells reflects a caspase-mediated proi.e., prominent membrane blebbing, loss of cytoarchi- Figure 1A) . We reasoned that this direct microinjection of plasmid-encoding Ha-RasG12V strong conservation in primary sequence indicated that [26] . In contrast, overexpression of Ki-RasG12V in one or more functions mediated by this segment were HEK293 cells gave robust apoptosis; substantial apoalso strongly conserved. In as much as all three segptosis was also induced by Ki-RasG12V Figure 3B ). We next surveyed Ha-RasG12V as compared with Ki-RasG12V could be an array of NORE/RASSF1 interactors isolated by twodue to weaker activation of a proapoptotic effector or to a stronger activation of an antiapoptotic outflow (or hybrid screens for their ability to bind all three NORE-both). The finding that Ha-RasG12V, E37G, an effector loop mutant that is unable to bind Raf or PI 3-kinase, elicits substantially greater apoptosis than Ha-RasG12V strongly supports the latter formulation. It is important to emphasize that, although the proapoptotic effect of Ki-RasG12V (and Ha-RasG12V, E37G; data not shown) is suppressed by coexpression with an active PI 3-kinase, Ras-induced apoptosis is not caused by poor or absent activation of an antiapoptotic output alone; rather, the proapoptotic effects of Ki-RasG12V and Ha-RasG12V, E37G are due to their ability to activate a proapoptotic stimulus that is not effectively counteracted by a concomitant antiapoptotic outflow. The interference experiments indicate strongly that the proapoptotic stimulus supplied by both Ki-RasG12V and Ha-RasG12V, E37G requires the participation of NORE and MST1. Thus, 
